Takeda Canada Inc. and Takeda GMBH (Takeda) brought an application under section 6 of the PM(NOC) Regulations.
May 19, 2015
On May 5, 2015, the Court of Appeal for Ontario dismissed Apotex’s appeal from the Ontario Divisional Court, which struck out Apotex’s claim.
May 11, 2015
On April 20, 2015, the Quebec National Assembly passed Bill 28.
May 08, 2015
On April 20, 2015, the Supreme Court heard Sanofi-Aventis’ appeal of the Federal Court of Appeal section 8 quantification decision with respect to the drug Ramipril.
April 29, 2015
Today, Industry Canada published proposed amendments to the Patented Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations).
Bayer Inc. (Bayer) distributes a combination oral contraceptive tablet under the brand name YAZ® (drospirenone and ethinylestradiol).
Prothonotary Lafrenière issued an order pursuant to section 6(5)(b) of the PM(NOC) Regulations striking all allegations relating to one of three patents.
April 16, 2015
Bill C-17, An Act to Amend the Food and Drugs Act (also referred to as the Protecting Canadians from Unsafe Drugs Act), received Royal Assent on November 6, 2014.
April 15, 2015
Janssen Inc [Janssen] sells infliximab under the brand name REMICADE®.
April 09, 2015
Insurers, like all businesses operating in Europe, are subject to European and domestic data protection laws.
April 08, 2015
Try searching our global site instead